107 related articles for article (PubMed ID: 12115063)
41. Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma.
Gluick T; Yuan Z; Libutti SK; Marx SJ
Endocr Relat Cancer; 2013 Dec; 20(6):L27-9. PubMed ID: 24127162
[No Abstract] [Full Text] [Related]
42. The in-vitro detection of the calcium-mobilising properties of mammary carcinoma.
Powles TJ; Easty DM; Easty GC; Neville AM
J Pathol; 1973 Jan; 109(1):Piv. PubMed ID: 4737064
[No Abstract] [Full Text] [Related]
43. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
[TBL] [Abstract][Full Text] [Related]
44. [A patient with a palpable nodule in the throat due to a cystic parathyroid adenoma].
van Zuilen AD; Koot RA; Mudde AH
Ned Tijdschr Geneeskd; 2004 May; 148(18):896-8. PubMed ID: 15152394
[TBL] [Abstract][Full Text] [Related]
45. Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors.
Arya AK; Singh P; Saikia UN; Sachdeva N; Dahiya D; Behera A; Rao SD; Bhadada SK
J Endocrinol Invest; 2020 Feb; 43(2):247-253. PubMed ID: 31535356
[TBL] [Abstract][Full Text] [Related]
46. Mutational analysis of the PTH 3'-untranslated region in parathyroid disorders.
Costa-Guda J; Lauter K; Naveh-Many T; Silver J; Arnold A
Clin Endocrinol (Oxf); 2006 Dec; 65(6):806-9. PubMed ID: 17121534
[TBL] [Abstract][Full Text] [Related]
47. Parathyroid FNA and hormone assay.
Derreberry T; Yaqub A
W V Med J; 2009; 105(5):30-4. PubMed ID: 19806869
[TBL] [Abstract][Full Text] [Related]
48. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
49. [Chromosome abnormalities in hyperparathyroidism: utility of comparative genomic hybridization in the study of parathyroid hyperplasias].
Afonso S; Cigudosa JC; Santamaría I; Otero A; Menárguez J; García Miranda JL
Nefrologia; 2003; 23 Suppl 2():2-6. PubMed ID: 12778845
[TBL] [Abstract][Full Text] [Related]
50. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
[TBL] [Abstract][Full Text] [Related]
51. Non-functioning mediastinal parathyroid adenoma with sarcoid-like granulomatous lymphadenopathy.
Bal A; Sachdeva MU; Joshi K; Behera A; Arora S; Gupta S
APMIS; 2007 Jun; 115(6):784-8. PubMed ID: 17550391
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
[TBL] [Abstract][Full Text] [Related]
53. GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism.
Kebebew E; Peng M; Wong MG; Ginzinger D; Duh QY; Clark OH
Surgery; 2004 Dec; 136(6):1261-6. PubMed ID: 15657585
[TBL] [Abstract][Full Text] [Related]
54. Intraoperative parathyroid hormone testing: what have we learned?
Proctor MD; Sofferman RA
Laryngoscope; 2003 Apr; 113(4):706-14. PubMed ID: 12671433
[TBL] [Abstract][Full Text] [Related]
55. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases.
Bergero N; De Pompa R; Sacerdote C; Gasparri G; Volante M; Bussolati G; Papotti M
Hum Pathol; 2005 Aug; 36(8):908-14. PubMed ID: 16112008
[TBL] [Abstract][Full Text] [Related]
56. The clinical significance and anatomic distribution of parathyroid double adenomas.
Bergson EJ; Heller KS
J Am Coll Surg; 2004 Feb; 198(2):185-9. PubMed ID: 14759773
[TBL] [Abstract][Full Text] [Related]
57. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions.
Saggiorato E; Bergero N; Volante M; Bacillo E; Rosas R; Gasparri G; Orlandi F; Papotti M
Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595
[TBL] [Abstract][Full Text] [Related]
58. Is there any connection between the presence of kidney stones in primary hyperparathyroidism and the location of an underlying adenoma?
Csupor E; Toth E; Meszaros S; Ferencz V; Szucs J; Lakatos P; Horányi J; Perner F; Horvath C
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):257-61. PubMed ID: 15926110
[TBL] [Abstract][Full Text] [Related]
59. Primary hyperparathyroidism: role of the preoperative oral calcium loading test in the differential diagnosis between adenoma and hyperplasia.
Hagag P; Kummer E; Weiss M
Calcif Tissue Int; 2008 Dec; 83(6):404-13. PubMed ID: 19020789
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
Wagner PL; Chen YT; Yantiss RK
Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
